NCT05615675

Brief Summary

The purpose of this study is to evaluate the effectiveness of virtual reality (VR) distraction in patients undergoing interventional pain procedures in the prone position. VR has been shown to improve patient experience during interventional pain procedures, however, many of these procedures are done in the prone position making VR a challenge. This study will evaluate the effect of a VR headset and support in patients undergoing prone interventional pain procedures compared to control.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 26, 2022

Completed
2 months until next milestone

First Posted

Study publicly available on registry

November 14, 2022

Completed
1.5 years until next milestone

Study Start

First participant enrolled

May 13, 2024

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 9, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 9, 2024

Completed
Last Updated

March 25, 2025

Status Verified

March 1, 2025

Enrollment Period

4 months

First QC Date

September 26, 2022

Last Update Submit

March 20, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • Anxiety Score

    State-Trait Anxiety Inventory (Self-reported anxiety instrument containing two separate 2-item subscales that measure trait (baseline) and state (situational) anxiety; Total range 20 to 80 with higher scores indicating greater anxiety).

    Immediately before procedure

  • Anxiety Score

    State-Trait Anxiety Inventory (Self-reported anxiety instrument containing two separate 2-item subscales that measure trait (baseline) and state (situational) anxiety; Total range 20 to 80 with higher scores indicating greater anxiety).

    Immediately after procedure

Secondary Outcomes (5)

  • Anxiety Score

    Immediately before procedure, during procedure, and immediately after procedure

  • Pain Score

    Immediately before procedure, during procedure, and immediately after procedure

  • Global Impression of Change

    Immediately after procedure

  • Patient Experience Satisfaction

    Immediately after procedure

  • Sedation Requirements

    During course of procedure

Study Arms (2)

Virtual Reality

EXPERIMENTAL

Patients undergo prone pain procedure with virtual reality distraction

Other: Virtual Reality Headset

Control

NO INTERVENTION

Patients undergo prone pain procedure without virtual reality distraction

Interventions

Patient uses a virtual reality headset and support during prone pain procedure

Also known as: Oculus Quest Virtual Reality Headset
Virtual Reality

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients aged 18 years old or older, who are referred to University of California Davis Pain Medicine Clinic and require an interventional pain procedure
  • English speaking and with the ability to understand oral and written instructions

You may not qualify if:

  • Pregnant women
  • Prisoners
  • Patients who have high risk of motion sickness, seizure disorder, or visual/hearing impairment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UC Davis Interventional Pain Clinic

Sacramento, California, 95817, United States

Location

MeSH Terms

Conditions

Anxiety DisordersPain

Condition Hierarchy (Ancestors)

Mental DisordersNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Michael Jung, MD MBA

    University of California, Davis

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Randomized controlled trial
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 26, 2022

First Posted

November 14, 2022

Study Start

May 13, 2024

Primary Completion

September 9, 2024

Study Completion

September 9, 2024

Last Updated

March 25, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will not share

Locations